Filing Details

Accession Number:
0001144204-18-059191
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-11-13 12:23:34
Reporting Period:
2018-11-07
Accepted Time:
2018-11-13 12:23:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1651407 Checkpoint Therapeutics Inc. CKPT () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
941841 Md A Lindsay Rosenwald 2 Gansevoort Street, 9Th Floor
New York NY 10014
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-11-07 2,100 $2.12 28,548 No 4 P Direct
Common Stock Acquisiton 2018-11-08 48,234 $2.24 76,782 No 4 P Direct
Common Stock Acquisiton 2018-11-09 49,666 $2.35 126,448 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The range of prices for the sale transactions on November 7, 2018, was $2.05 to $2.26, the range of prices for the sale transactions on November 8, 2018, was $2.19 to $2.34, and the range of prices for the sale transactions on November 9, 2018, was $2.30 to $2.44. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
  2. Includes restricted stock units which vest over various time periods, subject to Dr. Rosenwald's continued service on the board on such date.